Auris Medical AG Promotes Anne Sabine Zoller To General Counsel

ZUG, Switzerland, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced the promotion of Anne Sabine Zoller to General Counsel and member of the Executive Management team. Ms Zoller acquired extensive experience in Swiss and international corporate law as attorney and in-house counsel.

Prior to joining Auris Medical in April 2015 as Senior Legal Counsel, Ms Zoller was an attorney in the Corporate/M&A team of Homburger AG, a Zurich based law firm, and later Corporate/M&A Counsel with Straumann Group, a dental implant company headquartered in Basel. She obtained a PhD in law from the University of Zurich and an MBA from Melbourne Business School.

About Auris Medical

Auris Medical is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology. The Company is currently focusing on the development of treatments for acute inner ear tinnitus (AM-101) and for acute inner ear hearing loss (AM-111) by way of intratympanic injection with biocompatible gel formulations. In addition, Auris Medical is pursuing early-stage research and development projects. The Company was founded in 2003 and is headquartered in Zug, Switzerland. The shares of Auris Medical Holding AG trade on the NASDAQ Global Market under the symbol “EARS”.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC